Biotechnology Stocks I Performance Guide: MorphoSys AG (MOR)
MOR has no dividends.
Table and Chart of MOR Performance
See what a $1,000 investment in MOR is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MOR Returns | |
|---|---|
| Start Date | May-31-2018 |
| Start Price | $26.49 |
| End Date | May-07-2024 |
| End Price | $17.94 |
| # Prices | 73 |
| Min Date | Dec-30-2022 |
| Min Price | $3.58 |
| Max Date | Dec-31-2019 |
| Max Price | $35.67 |
| Total Return | -32.28% |
| Annualized Return | -6.21% |
| Current Value of $1,000 Purchase | $677 |
| Number Returns | 2,628 |
| Average Return | -26.53% |
| Number Profitable Returns | 634 |
| Percent Profitable Returns | 24.12% |
| Number Unprofitable Returns | 1,994 |
| Percent Unprofitable Returns | 75.88% |
| Profitable to Unprofitable Returns Ratio | 0.32 |
| MOR Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,714,369,000 |
| Beta | 0.603 | Price to Sales | 11.50 |
| Earnings per Share | $-1.4900 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 51.56 |
| PRICE DATA | |
| 52 Week High | $18.3 |
| 52 Week Low | $4.185 |
| Analyst Target Price | $15.55 |
| 50-Day Moving Average | $17.94 |
| 200-Day Moving Average | $11.03 |
| FINANCIAL DATA | |
| Revenue per Share | $1.716 |
| Revenue | $241,471,000 |
| Profit Margin | -190.6% |
| Return on Equity | -183.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MOR Compare Returns with S&P 500
MOR Trendline Chart
MOR Moving Average Chart
MOR Stock Return Map - See Patterns of Gains and Losses
MOR Stock Returns/Purchase Dates